Brief: Cortexyme - Q2 Loss Per Share $0.74

IRulya Therapeutics

09/08/2021 14:26

Aug 9 (Reuters) - Cortexyme Inc  CRTX.O :
    * Q2 LOSS PER SHARE $0.74
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.76 -- REFINITIV IBES
DATA
    * CURRENT CASH POSITION SUFFICIENT TO FUND OPERATIONS
THROUGH 2023
    * PHASE 2 REPAIR SUB-STUDY RESULTS EVALUATING PERIODONTAL
DISEASE
EXPECTED BY MID-NOVEMBER 2021
    * GAIN TRIAL TOP-LINE DATA FOR DISEASE MODIFICATION IN
ALZHEIMER'S
EXPECTED BY MID-NOVEMBER 2021
    * CASH, CASH EQUIVALENTS, AND SHORT AND LONG-TERM MARKETABLE
SECURITIES AS OF JUNE 30, 2021, WERE $153.5 MILLION

Source text for Eikon:  ID:nBw8FFRBfa 
Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))